At Brown University they’re working on something called the extracellular matrix – a way to help the body promote tissue healing and regeneration with minimal negative impact and without debilitating drugs. It could be a game changer for heart disease and a host of other ailments.
In this episode, we meet XM Therapeutics and the ecosystem at Brown Technology innovations that is working to make this amazing technology a reality for patients. Melissa Simon, the Director of Business Development at Brown Technology Innovations, and Karen Bulock from Brown Medical Biomedical Innovations work together to provide early funding and guidance so these amazing ideas that start in the research lab can make it to commercialization.
We’re also joined by Dr. Jeffrey Morgan, Professor of Pathology and Laboratory Medicine at Brown and Frank Ahmann the entrepreneur who BTI recruited to scale XM Therapeutics.
Learn about Brown Technology Innovations here.
Read more about this amazing advancement at XMThereapeutics.com.
And check out TheAngelNest.com for many more stories of innovative companies.
